National Policy Boosts Marine Biomedicine, Wenzhou Dongtou Chengyi Pharma Seizes Growth Opportunity

At the sixth meeting of the central financial and Economic Commission recently, it was clear that emerging industries such as marine biomedicine would be included in the national key development strategy. Based on this period of strategic opportunity, Wenzhou Dongtou sincerity pharmaceutical is expected to accelerate its development with policy support.

Since the beginning of this year, policies for marine economic development have been frequently issued to support the development of marine economy from the top-level design. Under the east wind of the policy, the concept stocks of marine biomedicine ushered in the opportunity of value revaluation. Taking listed companies as an example, sincerity pharmaceutical, with nearly 70% of the revenue of marine biomedicine, is firmly in the "leader" position in the industry.

As the first listed company deeply engaged in marine biomedicine in Zhejiang Province, Chengxin pharmaceutical has actively integrated into the national marine strategy. Relying on the two core businesses of ammonia sugar and fish oil, it has deeply arranged the field of marine biomedicine, showing a strong momentum of development.

It is understood that glucosamine hydrochloride, the core product of sincerity pharmaceutical, is a typical case of successful development of marine drugs. Its main raw material is chitin from crab shell and shrimp shell. Compared with similar products, it has unique advantages such as pure nature and no additives. Relying on the regional advantages of the National Marine ranch demonstration area in Dongtou District, Wenzhou, and the industrial layout in the field of marine economy over the years, sincere pharmaceutical has built a moat of marine biomedicine. At present, at the level of ammonia sugar products, the company has formed the advantage of full chain integration from raw material extraction, API to preparation production.

At the same time, sincerity pharmaceutical also launched an innovative layout in the field of fish oil. Taking the marine biomedical manufacturing project as the carrier, the company actively promotes the construction of high-purity fish oil EPA API project.

Source: China Blue News